In 2003, then Caltech Professor Raymond Deshaies co-founded Proteolix to develop a proteasome-inhibiting compound that would later lead to the billion-dollar cancer drug carfilzomib/Kyprolis®. The company was subsequently acquired by Onyx and then Amgen.
In this webinar, Dr. Deshaies (now SVP of Global Research at Amgen) will share with Dr. Barry Bunin (CEO, Collaborative Drug Discovery) the story behind the discovery of Kyprolis, as well as discuss the latest developments in areas related to PROTACs and COVID-19 biology. It will be a rare opportunity to get direct insights from a high-profile drug discovery pioneer that you don`t want to miss.
In addition, this will be the first chance for a sneak peak of CDD`s BioHarmony – a modern semantic drug data store that offers real-time data streams on thousands of drugs, including Kyprolis.
